Clinical trials
Pancreatitis clinical trials
Below are recruiting pancreatitis clinical trials, each written for real people, not researchers. We’re tracking 1,021 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT03643718Recruiting
Emergency surgery and trauma patient registry online
This trial is a web-based registry that collects information about people who need emergency surgical or non-surgical treatment for sudden (acute) problems. Your information can help doctors better understand and improve emergency care and decision-making.
PisaAges Any age - NCT03787056Recruiting
Blood test marker study in many cancer types
This study measures a blood marker called progastrin (at diagnosis and during treatment) to see how well it predicts response or outcomes. It may help doctors choose or monitor treatment more precisely for several cancer types.
BronAges 18 years+ - NCT05172310RecruitingPhase 1
PET scan study using a new tracer for solid tumors
This trial tests a special PET/CT scan using a new tracer (68Ga-FAPI) to help show tumors in the pancreas, bile ducts, stomach, or certain ovarian cancers. It may help doctors better see where cancer is in preparation for surgery or biopsy.
StockholmAges 19 years+ - NCT05155878Recruiting
Study of factors that predict outcomes for certain pancreas tumors
This study looks at what features of certain pancreas and nearby tumors or cysts might help predict outcomes. It uses existing medical records (and consent, if applicable) and may help doctors better estimate prognosis for patients in the future.
UmeåAges 18 years+ - NCT05257434Recruiting
Body composition test after liver, bile duct, or pancreas cancer surgery
This study looks at how well people do after surgery for liver, bile duct, or pancreas cancer, using a body composition test (the “inBody” test). It may help doctors understand which body changes after surgery are linked to better or worse recovery.
KochiAges 18–90 - NCT05620732Recruiting
CAR-T treatment for advanced stomach or pancreatic cancer
This trial tests a customized immune-cell treatment (CAR-T) for advanced stomach or pancreatic cancer that cannot be removed by surgery. It aims to use cells engineered to target a specific tumor marker to shrink cancer or slow its growth.
Shenzhen, GuangdongAges 18–75 - NCT05018663Recruiting
AI test of fluid samples from pancreatic cysts
This trial uses artificial intelligence (AI) to help interpret fluid/scraping samples taken with a needle from pancreatic cysts. You might be eligible if an ultrasound/endoscopy exam found a pancreatic cyst called a PSL and it’s safe for you to have that needle procedure (FNA/FNB).
Houston, TexasAges 18–100 - NCT05061680Recruiting
Balloon treatment for large bile duct stones
This trial looks at a procedure that uses a large balloon to help remove big stones from the bile duct. It may help people with large common bile duct stones who are safe for this approach.
HelsinkiAges 18–95 - NCT04998552Recruiting
CyberKnife radiation for certain pancreatic cancer patients after chemotherapy
This trial studies how safe CyberKnife is when used to treat some borderline resectable or locally advanced pancreatic cancers after chemotherapy. It may help patients by targeting the tumor with precise radiation, while researchers closely watch for side effects.
Pennington, New JerseyAges 18 years+ - NCT05556603Recruiting
Blood test trial to detect pancreatic cancer early
This trial studies whether a blood-based test can help detect pancreatic cancer (or strong signs of it) earlier than usual. The goal is to see how well “liquid biopsy” results match real diagnoses and risk levels.
Shanghai, Shanghai MunicipalityAges 40–75 - NCT04220931Recruiting
Botox shot to help prevent a pancreas leak after distal surgery
This trial studies whether injecting a Botox-like medicine into the pancreatic drainage area can help prevent a post-surgery pancreas fistula (a persistent leak). It’s for adults having a planned distal pancreatectomy, and it may help reduce complications after surgery.
ClichyAges 18 years+ - NCT06028724Recruiting
Looking for cancer mutations using a blood test
This study uses a blood test (liquid biopsy) to find genetic changes in advanced solid tumors. It may help doctors choose the right treatment and monitor how well it works over time.
Aviano, PordononeAges 18 years+ - NCT06065891Recruiting
Lymph node removal in pancreatic cancer surgery
This trial studies whether removing extra lymph nodes during surgery for pancreatic cancer can help find if the cancer has spread. It is for patients whose tumor is considered removable or borderline removable.
OdenseAges 18 years+ - NCT06150690Recruiting
Pancreatic islet study in patients having pancreas surgery
This trial studies pancreatic islets (cells that make insulin) from people who are having part or all of their pancreas removed. It may help researchers learn more about how the pancreas works in health and disease.
Düsseldorf, North Rhine-WestphaliaAges 18 years+ - NCT05604560RecruitingPhase 2
New drug combo before surgery for resectable pancreatic cancer
This trial tests two drugs, tislelizumab and SX-682, given before surgery for people with pancreatic cancer that can be removed. The goal is to see if this combination shrinks tumors and improves outcomes.
Baltimore, MarylandAges 18 years+ - NCT07862075RecruitingPhase 4
Inebilizumab for type 1 autoimmune pancreatitis
This trial tests a new treatment called inebilizumab for type 1 autoimmune pancreatitis, a condition where the immune system attacks the pancreas. The goal is to see if this treatment can reduce symptoms and prevent damage to the pancreas and other organs.
ShanghaiAges 18 years+ - NCT04282083Recruiting
Registry for adults with confirmed digestive neuroendocrine tumors
This is a registry study that collects medical information from adults with neuroendocrine tumors (NETs) that start in the digestive organs. It helps researchers understand these cancers better and may support future studies.
Rozzano, MilanAges 18 years+ - NCT06245330RecruitingPhase 1/Phase 2
Study of AST-001 for advanced solid tumors
This trial is testing a new drug called AST-001 for people with advanced solid tumors (including pancreatic cancer) that have not responded to standard treatments. The study aims to find the right dose and see how well the drug works.
Changchun, JinlinAges 18–70 - NCT06145074RecruitingPhase 2
Testing propranolol before surgery for pancreatic cancer
This trial tests if taking propranolol (a blood pressure medication) before surgery helps treat pancreatic cancer that can be removed. It aims to see if the drug is safe and works well.
CopenhagenAges 18 years+ - NCT05984810RecruitingPhase 2
Using a glowing dye to help see pancreatic cancer during surgery
This trial tests whether a special dye (SGM-101) can help surgeons see remaining cancer cells during surgery for pancreatic cancer that has been treated before surgery. It may lead to more complete removal of the tumor.
LeidenAges 18 years+ - NCT05187312Recruiting
Registry for advanced endoscopy procedures
This study is a registry that collects information about people who need an endoscopy procedure. It may help doctors learn which approaches work best and improve care over time.
StockholmAges 18 years+ - NCT05714124Recruiting
Testing liver procedures to treat tumors when surgery isn’t possible
This trial studies different ways to place treatments inside the liver to control liver tumors when they can’t be removed with surgery or ablation. It may help certain people by improving how well the tumor is treated while keeping liver function safer.
MilanAges 18 years+ - NCT06389552Recruiting
Long-term study of FOLFIRINOX after pancreatic cancer surgery
This study follows people with pancreatic cancer who are receiving a chemotherapy combination called FOLFIRINOX after surgery. The goal is to see how well the treatment works over time and how it affects long-term survival and cancer recurrence.
SeoulAges 19 years+ - NCT06403735RecruitingPhase 1
Study of QLC1101 for advanced solid tumors with KRAS G12D mutation
This trial tests a new drug, QLC1101, for people with advanced solid tumors that have a specific genetic change called KRAS G12D. It may be an option if you have tried other treatments or cannot take them.
Guangzhou, GuangdongAges 18 years+
Hear when a new Pancreatitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for pancreatitis?
- Yes. Clin2 currently lists 1,021 recruiting pancreatitis studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a pancreatitis trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a pancreatitis trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.